Canada - English - Health Canada

greer laboratories inc - standardized timothy grass pollen - liquid - 100000unit - standardized timothy grass pollen 100000unit - allergenic extracts

Canada - English - Health Canada

greer laboratories inc - standardized timothy grass pollen - liquid - 10000unit - standardized timothy grass pollen 10000unit - allergenic extracts

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - phleum pratense, quantity: 1 ml/ml (equivalent: phleum pratense, qty 50 mg/ml) - extract, liquid - excipient ingredients: glycerol; sodium chloride; sodium bicarbonate; water for injections - indicated use of allergenic extracts is for the diagnosis and treatment (hypo-sensitization therapy) of patients who experience allergic symptoms.

United States - English - NLM (National Library of Medicine)

alk-abello a s - phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense pollen - unii:65m88rw2eg) - phleum pratense pollen 2800 [bau] -       grastek®  is an allergen extract indicated as immunotherapy for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro  testing for pollen-specific ige antibodies for timothy grass or cross-reactive grass pollens. grastek is approved for use in persons 5 through 65 years of age.       grastek is not indicated for the immediate relief of allergic symptoms.       grastek is contraindicated in patients with: - severe, unstable or uncontrolled asthma  - a history of any severe systemic allergic reaction - a history of any severe local reaction after taking any sublingual allergen immunotherapy - a history of eosinophilic esophagitis - hypersensitivity to any of the inactive ingredients [gelatin, mannitol and sodium hydroxide] contained in this product [ s ee description ( 11 )].       risk summary       all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated b

Bangladesh - English - DGDA (Directorate General of Drug Administration)

eskayef pharmaceuticals ltd. mirpur. - tiemonium methylsulphate - injection - 5 mg/2 ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - timothy grass (phleum pratense) pollen allergen extract - oral lyophilisate - 75000sq-t

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

inmunotek - timothy grass (phleum pratense) pollen allergen extract; yorkshire fog (velvet grass, holcus lanatus) pollen allergen extract; cocksfoot (orchard grass, dactylis glomerata) pollen allergen extract; rye grass (lolium perenne) pollen allergen extract; meadow grass (kentucky blue grass, poa pratensis) pollen allergen extract; meadow fescue (festuca elatior) pollen allergen extract - solution for skin-prick test

United States - English - NLM (National Library of Medicine)

greer laboratories, inc. - festuca pratensis pollen (unii: a0wfq8p6n1) (festuca pratensis pollen - unii:a0wfq8p6n1) - festuca pratensis pollen 10000 [bau] in 1 ml - greer standardized grass pollen allergenic extracts are indicated for: - skin test diagnosis of patients with a clinical history of allergy to one or more of the following grass pollens: bermuda, kentucky blue (june), meadow fescue, orchard, perennial rye, redtop, sweet vernal, timothy. - immunotherapy for the reduction of grass pollen-induced allergic symptoms confirmed by positive skin test or by in vitro testing for pollen-specific ige antibodies for bermuda grass pollen, kentucky blue (june) grass pollen, meadow fescue grass pollen, orchard grass pollen, perennial rye grass pollen, redtop grass pollen, sweet vernal grass pollen, or timothy grass pollen. standardized grass pollen allergenic extracts are contraindicated in patients with: - severe, unstable or uncontrolled asthma - history of any severe systemic allergic reaction or any severe local reaction to subcutaneous allergen immunotherapy 8.1 pregnancy risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes. i

New Zealand - English - Medsafe (Medicines Safety Authority)

ebos group ltd - allergen extracts 100 pnu/ml (cocksfoot,timothy,kyblue,sweetvernal,per rye, m.fescue,bent); allergen extracts 1000 pnu/ml (cocksfoot,timothy,kyblue,sweetvernal,per rye, m.fescue,bent); allergen extracts 10000 pnu/ml (cocksfoot,timothy,kyblue,sweetvernal,per rye, m.fescue,bent) - suspension for injection - active: allergen extracts 100 pnu/ml (cocksfoot,timothy,kyblue,sweetvernal,per rye, m.fescue,bent) excipient: aluminium hydroxide phenol sodium chloride water for injection active: allergen extracts 1000 pnu/ml (cocksfoot,timothy,kyblue,sweetvernal,per rye, m.fescue,bent) excipient: aluminium hydroxide phenol sodium chloride water for injection active: allergen extracts 10000 pnu/ml (cocksfoot,timothy,kyblue,sweetvernal,per rye, m.fescue,bent) excipient: aluminium hydroxide phenol sodium chloride water for injection

Ireland - English - HPRA (Health Products Regulatory Authority)

alk-abello a/s - phleum pratense - solution for skin-prick test - 10 hep - tests for allergic diseases